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Oncology
Effectiveness and pitfalls of elective neck 
dissection in N0 laryngeal cancer
Efficacia e problematiche degli svuotamenti elettivi eseguiti su collo N0 nel cancro 
della laringe
A. DegAnello, g. gitti, g. MeccAriello, g. PArrinello, g. MAnnelli, o. gAllo
clinic of otolaryngology / Head and neck Surgery, Department of Surgical Sciences, University of Florence, italy
Summary
The aim of the study was to evaluate the efficacy and potential pitfalls of selective neck dissection of levels II-IV in controlling occult neck 
disease in clinically negative neck (cN0) of patients with laryngeal squamous cell carcinoma. Charts of 96 consecutive cN0 laryngeal can-
cer patients undergoing 122 neck dissections at the university of Florence from January 2000 to December 2004 were reviewed. N0 neck 
was defined with contrast enhanced computed tomography scan. Occult neck disease rate was 12.5%, involvement per level was: 47.6% at 
level II, 38.1% at level III, 9.5% at level IV. Six patients developed neck recurrence (6.25%) after selective neck dissection of levels II-IV 
within the first two years after treatment. In conclusion, selective neck dissection of levels II-IV is effective in N0 laryngeal squamous cell 
carcinoma; posterior limits of surgical resection are missing therefore if post-operative radiation is required, the field should be extended 
beyond the dissected levels. The low incidence of occult neck disease indicates the need to refine treatment strategy, restricting elective 
neck dissection only to supraglottic T2 with epilaryngeal involvement, supraglottic T3-4 and glottic T4 tumours, and considering a “wait 
and see” protocol implemented with imaging techniques and cytological assessments for other lesions.
Key  wOrDS:  Neck  dissection  •  Laryngeal  carcinoma  •  Selective  neck  dissection  •  Modified  radical  neck  dissection  •  Partial 
laryngectomy
rIaSSuNTO
Abbiamo valutato le possibili problematiche e l’efficacia dello svuotamento latero-cervicale selettivo dei livelli II-IV nel controllo delle 
metastasi occulte in pazienti affetti da carcinomi squamocellulari della laringe senza evidenza clinica di adenopatie laterocervicali (cN0). 
Abbiamo rivalutato le cartelle cliniche di 96 pazienti affetti da cancro della laringe cN0 sottoposti a svuotamento latero-cervicale selettivo 
dei livelli II-IV presso l’Università di Firenze tra il gennaio 2000 e dicembre 2004. Clinicamente il paziente è stato considerato cN0 dopo 
essere stato sottoposto a TC con mezzo di contrasto. Metastasi occulte latero-cervicali sono state riscontrate nel 12,5% dei casi. L’inte-
ressamento metastatico registrato per ciascun livello è stato: 47,6% livello II, 38,1% livello III, 9,5% livello IV. Sei pazienti sottoposti a 
svuotamento laterocervicale selettivo dei livelli II-IV hanno sviluppato una recidiva sul collo (6,25%) entro due anni dal trattamento. Lo 
svuotamento laterocervicale selettivo dei livelli II-IV è una procedura oncologicamente adeguata nei pazienti con collo N0. Poiché non 
esistono limiti posteriori nell’esecuzione dello svuotamento, il campo di irraggiamento dell’eventuale radioterapia postoperatoria dovreb-
be essere esteso a comprendere anche i livelli I e V. La bassa incidenza di metastasi occulte indica la necessità di rivedere le indicazioni 
chirurgiche riservando lo svuotamento elettivo solo ai tumori sopraglottici T2 con estensione epilaringea, sopraglottici T3-4 e ai glottici 
T4, sottoponendo gli altri pazienti a un attento follow-up strumentale e citologico. 
ParoLe chiave: Svuotamento latero-cervicale selettivo del collo • Carcinoma della laringe • Svuotamento radicale modificato • 
Laringectomia parziale
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Introduction
In patients with squamous cell carcinoma (SCC) of the 
larynx, the management of regional lymph nodes is a cru-
cial component of the overall treatment plan. If metas-
tases to the cervical lymph nodes are clinically evident at 
diagnosis, treatment of the neck is mandatory. The situa-
tion is more controversial when no clinical signs of neck 
disease are found (N0 neck). In this situation, the surgeon 
must decide whether to electively treat the neck or wait 
for metastases to develop and then treat the patient when-
ever they occur 1. The limitations in the identification of 
micrometastases and the negative impact of recurrences 
in the neck are still a challenge.
The lymphatic tumour spread to the neck follows predict-
able paths 2-6; this evidence justified the development of 
selective neck dissection (SND) for removing only those 
levels at risk. The SND of levels II-IV is, therefore, con-
sidered adequate in patients with cN0 laryngeal cancer 7-9. 
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Furthermore, in order to minimize post-operative mor-
bidity, it has recently been proposed by several authors 
to carry out a super-selective dissection of levels IIa-III 
because sub-level IIB and level IV are seldom involved 
without involvement of sub-level IIa and level III 10-15.
The present report refers to a series of 96 consecutive cN0 
laryngeal cancer patients treated at the Clinic of Otolaryn-
gology-head & Neck Surgery of the University of Flor-
ence, between 2000 and 2004 with a critical analysis of 
the results and potential pitfalls in SND II-IV.
Material and methods
Inclusion criteria to define N0 neck, in laryngeal cancer 
patients in this series, were based upon characteristics of 
detectable lymph nodes at contrast enhanced CT scan: 
lesser diameter < 10 mm, absence of central necrosis, 
absence of contrast enhancement of lymph node capsule. 
The  medical  records  of  96  consecutive  patients  with 
SCC of the larynx matched these criteria and represent 
the source data for this study. None of these patients had 
ever received radiotherapy or chemotherapy and all were 
submitted to surgery at the otolaryngology-head & Neck 
Surgery Clinic of the university of Florence, between 
January 2000 to December 2004 and then observed at 
strict follow-up. The uICC-aJCC TNm 6th edition stag-
ing system 15 was used for the staging of patients. The 
population study (Table I) comprised 80 males and 16 
females, with a mean age of 63 years (median 67, range 
38-82). Of these, 57 presented a supraglottic localiza-
tion of laryngeal SCC, staged as follows: 11 T1, 24 T2, 
10 T3, and 12 T4a; 39 presented a glottic localization 
staged as follows: 20 T2, 17 T3, and 2 T4a. Of these, 
14 had a total laryngectomy (all T4a cases with massive 
extra-laryngeal extension), in the remaining 82 cases a 
conservative approach was performed according to tu-
mour site and stage: 31 transoral CO2 laser resections, 16 
supraglottic horizontal laryngectomies; 33 supracricoid 
partial laryngectomies (21 crico-hyoid-pexis: chP and 
12 crico-hyoid-epiglotto-pexis: cheP) and 2 hemilaryn-
gectomies. a total of 122 elective neck dissections were 
performed: in 23 cases, a modified radical neck dissec-
tion (mrND) and in 64 cases a SND II-IV; in 35 patients, 
a contralateral neck dissection was also performed: 4 
mrND and 31 SND II-IV. all mrNDs were performed 
preserving the internal jugular vein, sternocleidomastoid 
muscle and spinal accessory nerve (this type of neck dis-
section was performed in the early period of the series 
before institutional consolidation of SND II-IV).
each neck specimen was divided into levels by the sur-
geon and sent for pathological analysis, it was then sec-
tioned in a routine manner and studied by the pathologist. 
Lymph nodes were mainly studied on a single section 
(double section only in lymph nodes with larger diameter 
> 10/15 mm).
Of the 96 patients, 19 (19.8%) received post-operative 
radiotherapy with standard fractioning of 200 cgy daily 
for 5 days a week. The average dose of irradiation was 
56.8 gy (50-65 gy). indications for post-operative radio-
therapy included advanced stage of the primary tumour, 
positive margin, presence of 2 or more occult positive 
nodes and lymph node metastases with extra capsular tu-
mour spread (eCS). The radiation was delivered to the 
primary and both neck sides. In the case of positive mar-
gins and eCS, chemotherapy was added to post-operative 
radiation. Follow-up was for a minimum of 5 years or un-
til death in all patients (mean 90 ± 19 months, min. 63 and 
max. 133).
Statistical analysis
The statistical analysis was performed with an IBm com-
puter using STaTa (Stata Corporation, College Station, 
TX, uSa). Fisher’s exact test was used for categorical 
variables and Student’s t-test for continuous variables to 
Table I. Patient overview.
No. patients 96
Sex
   Male 80
   Female 16
Site of T
   Supraglottic (57)
      T1 11
      T2 24
      T3 10
      T4a 12
   Glottic (39)
      T2 20
      T3 17
      T4a 2
Type of Surgery
   Total Laryngectomy 14
   Hemilaryngectomy 2
   CHP 21
   CHEP 12
   SPL 16
   CO2 laser 31
Neck procedures (122)
   Homolateral mRND 23
   Homolateral SND II-IV 64
   Contralateral mRND 4
   Contralateral SND II-IV 31
CHP: crico-hyoid-pexy; CHEP: crico-hyoid-epiglotto-pexy; SPL: Supraglottic 
horizontal Partial Laryngectomy; mRND: modified Radical Neck Dissection; SND: 
Selective Node Dissection.a. Deganello et al.
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compare the outcomes in SND II-IV treated patients ver-
sus those who underwent mrND. The actuarial survival 
time was defined as the interval between the date of sur-
gery and either the date of the last consultation for cen-
sored observations or the date of death for uncensored ob-
servations. The disease-free interval was measured on the 
basis of the dates of surgery and the diagnosis of first re-
currence. actuarial survival and loco-regional control was 
studied for the SND II-IV group and mrND group and 
for pN0 and pN+ groups with the Kaplan-meier method, 
differences between groups were studied by log rank test. 
Statistical significance was set at p < 0.05.
Results
a) Histopathological findings
Occult neck disease was documented in 12 out of 96 pa-
tients, 12.5% (Table II). In the 122 elective neck dissec-
tions (27 mrND and 95 SNDII-IV), occult neck metas-
tases were found in 12 specimens (9.8%, 7 SND II-IV and 
5 mrND), the pathological staging was pN1 in 9 cases, 
pN2b in 2 cases and pN2c in one case (Table II). The in-
cidence of occult neck disease was 15.7% for supraglot-
tic tumours (9 of 57: 4T2 16.6%, 3T3 30%, 2T4a 16.6%) 
and 10.3% for glottic tumours (3 of 39: 1T3 5.8%, 2T4a 
100%).
The average number of lymph nodes examined by pathol-
ogists was 31 per neck (range 25-42). a histopathological 
node negative neck was documented in 110 neck dissec-
tion specimens. eCS in occult metastasis was document-
ed in two nodes from one pN2b neck after mrND. The 
total number of occult positive nodes was 21: 10 located 
at level II (47.6%), 8 at level III (38.1%), 2 at level IV 
(9.5%), none at level V and only 1 (5.3%) was found in 
level I in a patient with positive nodes at level II and III 
who received a mrND.
b) Neck relapse
Six patients developed a neck recurrence (6.25%) in a 
previously dissected neck within the first 2 years after 
treatment (Fig. 1). among these patients, 4 developed 
regional  recurrence  without  concomitant  local  failure 
(at 6, 11, 14 and 17 months after surgery) while in the 
remaining 2 cases the neck recurrence was documented 
in association with a local failure, in one case after a su-
praglottic laryngectomy for pT2N0 and in another after 
total laryngectomy with post-operative radiotherapy for 
a pT4aN2c, at the 10th and 8th month, respectively. all 
recurrences affected necks previously treated with SND 
II-IV (6 of 95 vs 0 of 27 for the mrND group), however, 
this difference is not statistically significant (p = 0.336). 
The 4 neck relapses without concomitant local failure 
were recorded in 3 clinically and histologically negative 
necks (one supraglottic T1, one glottic T2 and one sup-
raglottic T3) and one in a patient who had undergone to-
tal laryngectomy and post-operative radiotherapy on ac-
count of a pT4aN1 glottic cancer. Looking at the sites of 
recurrence (Fig. 2), it was found that for the pN0 cases, 
neck failure was located at the posterior limit of the re-
section at levels II and III, while the sites of failure in the 
2 cases cN0/pN+ were located outside the dissected field 
(levels I and V, respectively). a salvage radical neck dis-
section (rND) followed by post-operative radiotherapy 
was performed in 3 neck relapses without primary fail-
ure, resulting in 3 patients free of disease at 25, 28 and 
31 months. a rND was performed for the pN+ previ-
ously submitted to total laryngectomy and post-opera-
tive radiotherapy, the patient died following a new recur-
rence in the mastoid area. Of the remaining 2 patients 
with loco-regional recurrence, one underwent palliative 
treatment with chemo-radiation (the patient had under-
gone a total laryngectomy with post-operative radiation 
for a pT4aN2c) and died with peristomal recurrence, the 
other one was saved by a total laryngectomy (glottic re-
currence after supraglottic laryngectomy) and rND plus 
radiotherapy and is free of disease at 63 months. The 
5-year neck recurrence rate as estimated by the Kaplan-
meyer method, for all patients (n = 96), was 4.7%. No 
significant difference in the rate of 5-year neck recur-
rence was documented between node positive (pN+) and 
node negative (pN0) groups (p = 0.893) between sur-
gery only and combined therapy groups (p = 0.490), as 
well as between SND II-IV and mrND type III groups 
(p = 0.425). No cases of neck failure affecting a non-
dissected neck side was recorded in this series.
Table II. Occult neck metastases overview.
By type of neck dissections (N = 122)
   SNDI-IV 7/95 (7.36%)
   mRND 5/27 (18.51%)
By T size and site
   Supraglottic (N = 9) 9/57 (15.7%)
      T2 4/24 (16.6%)
      T3 3/10 (30%)
      T4a 2/12 (16.6%)
   Glottic (N = 3) 3/39 (10.3%)
      T3 1/17 (5.8%)
      T4a 2/2 (100%)
By positive nodes (N = 21) for neck level
   Level I 1/21 (5.3%)
   Level II 10/21 (47.6%)
   Level III 8/21 (38.1%)
   Level IV 2/21 (9.5%)
   Level V 0/21 (0%)
mRND: modified Radical Neck Dissection; SND: Selective Node Dissection.effectiveness and pitfalls of elective neck dissection in N0 laryngeal cancer
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c) Local relapse
a total of 14 patients (14.6%) developed local recurrence 
in absence of regional relapse, all of whom were initially 
pN0 (Fig. 2). a total of 12 patients received salvage sur-
gery: 2 transoral CO2 laser resections and 1 supra-cricoid 
partial laryngectomy on account of failure after previous 
laser surgery; 9 total laryngectomy after previous supra-
glottic and supracricoid partial laryngectomy (4 and 5, re-
spectively). During total laryngectomy, we also performed 
a contralateral SND II-IV in 5 patients previously pN0 
who had received a SNDII-IV initially, no occult neck dis-
ease was found. Two patients presented with recurrence 
after total laryngectomy and post-operative radiotherapy 
(one peristomal and the other at the neopharynx), these 
patients received palliative chemotherapy but died from 
the condition.
Discussion
ultrasound (uS) images and positron emission tomogra-
phy (PeT) are, today, used in clinical practice to stage 
patients with head and neck tumours and might be use-
ful in the case of lymph nodes with uncertain character-
istics. Sensitivity and specificity of diagnostic images to 
stage neck lymph nodes could, therefore, improve and the 
incidence of clinically negative lymph node could be re-
duced. Nevertheless, subcentimetric metastasis are still a 
challenge, however recently encouraging data are emerg-
ing  from  computed  tomography  perfusion  (cTP)  scan 
that has been shown to depict small, subcentimetric nodal 
metastases even less than 1 cm in size. however, this tech-
nique needs to be further evaluated since, to date, the role 
of cTP imaging in the discrimination of malignant from 
benign lymph nodes has been investigated in a limited 
number of studies 16-18.
In this series, an incidence of occult neck metastases of 
12.5% was found, these data reflect an increased accuracy 
for the pre-operative assessment of cN0 neck compared 
to 18% for occult neck disease documented in a series 
treated during the 1990s in our Institute 19. This more ac-
curate estimate in clinical staging is certainly related to 
the policy of considering cN0 only patients without any 
suggestive sign of lymph node metastasis at contrast en-
hanced CT scan.
Nevertheless, does this low rate of occult disease justi-
fy an elective procedure which is beneficial only in one 
tenth of the treated population? This aspect is probably 
the most important pitfall arising from our series, clearly 
indicating the need to refine treatment strategies aimed 
at better characterization of high risk patients for occult 
neck disease.
For supraglottic T2 tumours, an incidence of occult neck 
disease of 16.6% (4 of 24) was found, however in 14 cases 
with tumour involving the epilaryngeal portion of the su-
praglottis (suprahyoid epiglottis, aryepiglottic folds, ary-
tenoids), the incidence was 21.4% (3 of 14) while in the 
10 T2 cases, without epilaryngeal involvement, the inci-
dence was 10% (1 of 10). Therefore, our data indicate that 
it would be appropriate to reserve elective neck dissec-
tion only for cases of supraglottic T2 with epilaryngeal 
involvement,  supraglottic T3-4  and  glottic T4  tumours 
Fig. 1. Site of recurrence, treatment and 
results of T and neck failures.
Fig. 2. Analysis of the pattern of neck failure.a. Deganello et al.
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and considering a “wait-and-see” protocol implemented 
with imaging techniques and cytological assessments to 
be more appropriate for “other lesions” in order to avoid 
unnecessary overtreatment.
at present, to decrease postoperative morbidity as much 
as possible, super-selective neck dissection at levels IIa-
III has been advocated by several authors 11-13 20-22. Data 
emerging from results of the present study might sustain 
this  approach  since  no  isolated  metastases  at  level  IV 
were found, in this series; unfortunately, we are unable to 
provide data on sublevel IIb.
as far as concerns the effectiveness of staging procedure, 
SND II-IV revealed 7 of 10 necks with occult metastas-
es (not revealing 3 neck recurrences on pN0 that devel-
oped during follow-up without primary site recurrence); 
mrND revealed 5 of 5 cases of occult neck disease and 
no relapses were documented in the group. Nevertheless, 
only one case showed a metastasis at level I, but positive 
lymph nodes at level II and level III were found, and these 
would have been detected by SND II-IV.
Serial sections for pathologic lymph-node examination 
and other immunohistochemical or bio-molecular assess-
ments allow detection of micrometastases and/or isolated 
tumour cells that could be otherwise missed with standard 
sectioning 23 24. In fact, this could have been the case for the 
3 before-mentioned pN0 necks for which it cannot be ex-
cluded that standard lymph node sectioning did not detect 
minimal neck disease. Nevertheless, these techniques are 
not routinely used in clinical practice because of the high 
costs. moreover, the utility of these extended techniques 
have the most impact on clinically N0 patients for whom 
the sentinel lymph node biopsy technique may eventually 
become the standard of care 25.
From our data, we could make comment about post-opera-
tive radiotherapy: in cases of documented occult neck dis-
ease, post-operative radiotherapy should include all neck 
levels, since the finding of metastasis at levels other than 
II-IV is not infrequent in this situation. we have observed 
two neck relapses, respectively, at level I and level V, in two 
pN+  patients  that  received  post-operative  radiation.  The 
analysis of the post-operative radiation field revealed that it 
was limited to the dissected levels, this non-surgical pitfall 
should be avoided. The results, in terms of regional control, 
indicate that no failure was recorded in the mrND group 
while 6 neck relapses were seen in the SND II-IV group. 
These data however, must be further analyzed because, for 3 
patients, the regional failure is hardly imputable to the possi-
ble surgical inadequacy of SND II-IV: 2 patients were path-
ologically staged pN+ after SND II-IV and also received 
post-operative radiotherapy as initial treatment, and in one 
patient recurrence was detected in the neck with local sup-
raglottic failure. The analysis of the pattern of neck failure 
is interesting (Fig. 2): in patients cN0/pN0, we found that 
all recurrences involved the upper posterior or mid-posterior 
limit of the dissection at levels II.
This site of failure seems to suggest that SND II-IV was 
less than complete, from the surgical point of view, high-
lighting a technical question regarding the absence of a 
clear anatomic separation between the posterior limit of 
levels II-III-IV and the anterior limit of level V. During 
surgery, we set this limit at the posterior edge of the ster-
nocleidomastoid  muscle,  when  encountering  the  emer-
gency  of  the  branches  of  the  cervical  plexus  (that  are 
usually preserved), however an exact anatomic boundary 
is lacking. Nevertheless, all necks presenting recurrence 
initially  staged  pN0  were  successfully  salvaged  with 
rND and post-operative radiotherapy. The present study, 
not unlike previous reports from our group 26 27, indicates 
that SND II-IV is oncologically adequate for the elective 
surgical treatment of N0 laryngeal patients, but a better 
codification of the high risk population must be further 
studied to avoid useless overtreatment.
Conclusions
These results suggest that even if SND II-IV is effective in 
controlling occult neck disease, the indication for elective 
neck treatment might be less than compelling in most cN0 
laryngeal cancer patients, therefore it would be appropri-
ate to reserve elective neck dissection only for supraglot-
tic T2 with epi-laryngeal involvement, supraglottic T3-4 
and glottic T4 tumours. Our data also suggest that if ra-
diotherapy is indicated for a pN+ neck treated with SND 
II-IV, then the radiation field should be extended beyond 
the surgical limits of the dissection, encompassing also 
levels I and V.
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